Quadrant Future Tek's IPO, oversubscribed 48.99 times, aims to raise funds for specialty cable division and railway projects.

Quadrant Future Tek IPO receives overwhelming response, closes Thursday with price band of ₹275-290, funds for long-term ...

The issue received bids of 9,18,47,850 shares against the offered 57,99,999 equity shares, at a price band of ₹275-290, ...

Maze Therapeutics has submitted its pitch for an initial public offering after disclosing a $115 million Series D, forging a ...

The Grey Market Premium (GMP) for Quadrant Future Tek's IPO is currently Rs 210 as of January 7, 2024, at 7:00 AM. With the ...

A day before the IPO opening, Quadrant Future Tek has garnered ₹130.5 crore from anchor investors. Foreign and Domestic ...

Quadrant Future Tek raised ₹130.5 crore from anchor investors ahead of public issue. The IPO will open for public bidding on ...

India-based drug manufacturer Anthem Biosciences has its sights on going public with an IPO that could raise 34 billion ...

Quadrant Future Tek has raised Rs 131 crore from anchor investors, with notable allocations from Bengal Finance and Shine ...

Quadrant Future Tek on Monday said it has raised over Rs 130 crore from anchor investors a day before its initial share sale ...

Quadrant Future Tek secures Rs 130.5 crore from anchor investors ahead of its IPO, set to open for public subscription soon.

The IPO is entirely a fresh issue of up to Rs 290 crore, and the company has priced its issue between Rs 275 and Rs 290 per ...